For patients dealing with stubborn soft-tissue injuries, post-surgical recovery, or chronic inflammation, either peptide is worth discussing with a qualified provider
Yes, when prescribed and monitored by a qualified provider
Providing that it may be induced rapidly, and then persisting for hour and day periods, this damaging effect is obviously part and parcel of general NSAIDs-toxicity, including gastric and small intestine ulcers, hepatotoxicity and encephalopathy (3, 8-14)
Anything less than 200 pg/ml is generally considered to be a deficiency
(Youll see it mis-cited around the web as Kannt et al. the correct first author is Awosemo
BPC-157 is generally well-tolerated, but some potential side effects may include: Consult a healthcare provider if you experience any persistent or concerning symptoms